Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study
- PMID: 27434092
- PMCID: PMC4951149
- DOI: 10.1371/journal.pone.0159223
Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study
Abstract
Recently, the intestinal microbiota has been emphasised as an important contributor to the development of metabolic syndrome. Dietary fibre may exert beneficial effects through modulation of the intestinal microbiota and metabolic end products. We investigated the effects of a diet enriched with two different dietary fibres, arabinoxylan and resistant starch type 2, on the gut microbiome and faecal short-chain fatty acids. Nineteen adults with metabolic syndrome completed this randomised crossover study with two 4-week interventions of a diet enriched with arabinoxylan and resistant starch and a low-fibre Western-style diet. Faecal samples were collected before and at the end of the interventions for fermentative end-product analysis and 16S ribosomal RNA bacterial gene amplification for identification of bacterial taxa. Faecal carbohydrate residues were used to verify compliance. The diet enriched with arabinoxylan and resistant starch resulted in significant reductions in the total species diversity of the faecal-associated intestinal microbiota but also increased the heterogeneity of bacterial communities both between and within subjects. The proportion of Bifidobacterium was increased by arabinoxylan and resistant starch consumption (P<0.001), whereas the proportions of certain bacterial genera associated with dysbiotic intestinal communities were reduced. Furthermore, the total short-chain fatty acids (P<0.01), acetate (P<0.01) and butyrate concentrations (P<0.01) were higher by the end of the diet enriched with arabinoxylan and resistant starch compared with those resulting from the Western-style diet. The concentrations of isobutyrate (P = 0.05) and isovalerate (P = 0.03) decreased in response to the arabinoxylan and resistant starch enriched diet, indicating reduced protein fermentation. In conclusion, arabinoxylan and resistant starch intake changes the microbiome and short-chain fatty acid compositions, with potential beneficial effects on colonic health and metabolic syndrome.
Trial registration: ClinicalTrials.gov NCT01618526.
Conflict of interest statement
Figures




Similar articles
-
Addition of arabinoxylan and mixed linkage glucans in porcine diets affects the large intestinal bacterial populations.Eur J Nutr. 2017 Sep;56(6):2193-2206. doi: 10.1007/s00394-016-1263-4. Epub 2016 Jul 11. Eur J Nutr. 2017. PMID: 27401929
-
Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial.Clin Nutr. 2020 Jan;39(1):67-79. doi: 10.1016/j.clnu.2019.01.012. Epub 2019 Feb 19. Clin Nutr. 2020. PMID: 30827722 Clinical Trial.
-
Effects of dietary fibre and protein content on intestinal fibre degradation, short-chain fatty acid and microbiota composition in a high-fat fructose-rich diet induced obese Göttingen Minipig model.Food Funct. 2020 Dec 1;11(12):10758-10773. doi: 10.1039/d0fo02252g. Epub 2020 Nov 24. Food Funct. 2020. PMID: 33231591
-
Conserved and variable responses of the gut microbiome to resistant starch type 2.Nutr Res. 2020 May;77:12-28. doi: 10.1016/j.nutres.2020.02.009. Epub 2020 Feb 22. Nutr Res. 2020. PMID: 32251948 Free PMC article. Review.
-
Role of resistant starch in improving gut health, adiposity, and insulin resistance.Adv Nutr. 2015 Mar 13;6(2):198-205. doi: 10.3945/an.114.007419. Print 2015 Mar. Adv Nutr. 2015. PMID: 25770258 Free PMC article. Review.
Cited by
-
An Overview on Fecal Branched Short-Chain Fatty Acids Along Human Life and as Related With Body Mass Index: Associated Dietary and Anthropometric Factors.Front Microbiol. 2020 May 27;11:973. doi: 10.3389/fmicb.2020.00973. eCollection 2020. Front Microbiol. 2020. PMID: 32547507 Free PMC article.
-
Extraction and characterisation of arabinoxylan from brewers spent grain and investigation of microbiome modulation potential.Eur J Nutr. 2021 Dec;60(8):4393-4411. doi: 10.1007/s00394-021-02570-8. Epub 2021 May 31. Eur J Nutr. 2021. PMID: 34057578 Free PMC article.
-
Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.Food Chem Toxicol. 2020 Sep;143:111558. doi: 10.1016/j.fct.2020.111558. Epub 2020 Jul 5. Food Chem Toxicol. 2020. PMID: 32640331 Free PMC article. Review.
-
Prevotella abundance and salivary amylase gene copy number predict fat loss in response to wholegrain diets.Front Nutr. 2022 Aug 22;9:947349. doi: 10.3389/fnut.2022.947349. eCollection 2022. Front Nutr. 2022. PMID: 36071931 Free PMC article.
-
The Impact of Yoyo Dieting and Resistant Starch on Weight Loss and Gut Microbiome in C57Bl/6 Mice.Nutrients. 2024 Sep 17;16(18):3138. doi: 10.3390/nu16183138. Nutrients. 2024. PMID: 39339738 Free PMC article.
References
-
- Hartvigsen ML, Gregersen S, Laerke HN, Holst JJ, Bach Knudsen KE, Hermansen K. Effects of concentrated arabinoxylan and beta-glucan compared with refined wheat and whole grain rye on glucose and appetite in subjects with the metabolic syndrome: a randomized study. European journal of clinical nutrition. 2014;68(1):84–90. 10.1038/ejcn.2013.236 - DOI - PubMed
-
- McIntosh GH, Noakes M, Royle PJ, Foster PR. Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men. The American Journal of Clinical Nutrition. 2003;77(4):967–74. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical